Skip to main content
. 2019 Nov;16(4):784–796. doi: 10.20892/j.issn.2095-3941.2019.0143

1.

1

Changes in ATRX, TP53 and IDH1 genes in glioma. (A) Genetic status of ATRX, TP53, IDH1, CDKN2A and CDKN2B in glioma patients. (B) Frequency of ATRX, TP53, IDH1, CDKN2A and CDKN2B alteration in LGGs and glioblastoma multiforme (GBM).